oxymatrine has been researched along with Cancer of Cervix in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| An, P; Chang, LH; Chen, KL; Gao, Q; Huang, C; Li, M; Li, ZF; Su, BS; Yang, J | 1 |
| Chen, Y; Gao, Y; Li, F; Li, W; Liu, J; Pei, Z; Wu, R; Yang, Y; Zeng, J; Zhou, H | 1 |
2 other study(ies) available for oxymatrine and Cancer of Cervix
| Article | Year |
|---|---|
Oxymatrine induces apoptosis in human cervical cancer cells through guanine nucleotide depletion.
Topics: Alkaloids; Animals; Antineoplastic Agents; Apoptosis; Caspases; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Female; Guanine Nucleotides; Humans; IMP Dehydrogenase; Mice; Mice, Inbred BALB C; Mice, Nude; Mitochondria; Neoplasms, Squamous Cell; Quinolizines; Signal Transduction; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays | 2014 |
Oxymatrine inhibits the proliferation of CaSki cells via downregulating HPV16E7 expression.
Topics: Alkaloids; Antimalarials; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Female; Humans; Neoplasm Recurrence, Local; Papillomavirus E7 Proteins; Quinolizines; RNA, Messenger; RNA, Small Interfering; Uterine Cervical Neoplasms | 2016 |